Conférence

Standardizing G8 evaluation

Réalisation : 7 novembre 2014 Mise en ligne : 7 novembre 2014
  • document 1 document 2 document 3
  • niveau 1 niveau 2 niveau 3
  • audio 1 audio 2 audio 3
Descriptif

Non-pharmaceutical innovations and public health

Management of the frail elderly with cancer is a challenge. Beside a poor outcome as compared to younger subjects, physicians will face increased risk of treatment-induced toxicity but also unexpected adverse events because of the underlying comorbidities and potential major consequences of these toxicities on the outcome because of frailty. In depth evaluation of the patient through geriatric assessment has been demonstrated as predictive of these adverse events but is time-consuming so that only a minority of cancer treatment hospitals will be able to propose it. Screening is part of the solution and G8 one of the best questionnaires currently available. Yet we have to go beyond this step and precisely define what to do for the unfit patients that we are now able to identify.

Cette présentation a été donnée dans le cadre du ScientificBRIO Day 2 organisé annuellement par le SIRIC BRIO et qui a pour but de réunirtous les acteurs du SIRIC BRIO et plus largement de la cancérologie à Bordeaux.

 

Intervenants
Thèmes
Notice
Langue :
Anglais
Crédits
Université de Bordeaux - Service Audiovisuel et Multimédia (Production), Université de Bordeaux - Service Audiovisuel et Multimédia (Publication), Université de Bordeaux - Service Audiovisuel et Multimédia (Réalisation)
Conditions d'utilisation
Creative Commons (BY NC)
Citer cette ressource:
Univ Bordeaux. (2014, 7 novembre). Standardizing G8 evaluation. [Vidéo]. Canal-U. https://www.canal-u.tv/75293. (Consultée le 4 juillet 2022)
Contacter

Dans la même collection

  • BRIO support to scientists
    Conférence
    00:13:28
    BRIO support to scientists
    Dessis
    Damien

    BRIO management team was voluntarily built upon various competencies from different horizons (industry, charity…) to provide a broad skillset which aims at supporting the Bordeaux cancer research

  • Bordeaux Cancer Initiative
    Conférence
    00:16:54
    Bordeaux Cancer Initiative
    Dessis
    Damien
    Elustondo
    Frédéric

    Translational science : how to move from biology to clinical applications Upon request of the University, the SIRIC was mandated to develop a transversal cancer axis at the University. The axis

  • Multisarc
    Conférence
    00:13:08
    Multisarc
    Italiano
    Antoine

    Translational science : how to move from biology to clinical applications Soft-tissues sarcomas represent an heterogeneous group of tumors. Stadard of care is surgical resection followed by

  • Curing leukemia ?
    Conférence
    00:19:52
    Curing leukemia ?
    Mahon
    François-Xavier

    Non-pharmaceutical medical innovations and public health The use of tyrosine kinase inhibitors (TKIs) targeted against the BCR-ABL1 oncoprotein has proven remarkably successful in chronic myeloid

  • Innovation reimbursement
    Conférence
    00:09:10
    Innovation reimbursement
    Fillatreau
    Christian

    Interface technology/clinical/SHS/public health : case study interventional radiology Novel diagnostic and therapeutic strategies is a continuum of 3 strongly associated phases : clinical

  • Technique, research and benefits
    Conférence
    00:22:10
    Technique, research and benefits
    Grenier
    Nicolas
    Palussière
    Jean

    Interface technology/clinical/SHS/public health : case study interventional radiology   >> Jean Palussière Radiology in oncology or so called interventional oncology is now considered by certain

Avec les mêmes intervenants

Sur le même thème